Concepedia

Author

Vijay Chauthaiwale

Torrent Pharma (India)

Also Known As

V Chauthaiwale, V M Chauthaiwale, V. Chauthaiwale, Vijay Chauthaiwale, Vijay M Chauthaiwale, Vijay M. Chauthaiwale

26

Publications

601

Citations

16

H-Index

54

Concepts

All Affiliations

Torrent Pharma (India)National Chemical LaboratoryUniversity of Tennessee at KnoxvilleNational Eye Institute
VC

About

Vijay Chauthaiwale is an author at Torrent Pharma (India) specializing in medicine, pharmacology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

288

2

Health Sciences

2

2

73

3

Engineering

1

1

25

4

Social Sciences

1

1

14

5

Biochemistry

1

1

16

Vijay Chauthaiwale

×

15

Publications

455

Citations

14

H-Index

YearCitations

TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes

Deepa Joshi, Ram Kumar Gupta, Amita Dubey,

Journal of Cardiovascular Pharmacology

2009

53

pRb and p107 regulate E2F activity during lens fiber cell differentiation

Anuradha Rampalli, Chun Gao, Vijay Chauthaiwale,

Oncogene

1998

47

TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high‐fat diet

Federica Cioffi, Shitalkumar Zambad, Laxmikant Chhipa,

The FASEB Journal

2010

43

Cell cycle regulation in the lens: Proliferation, quiescence, apoptosis and differentiation

Peggy S. Zelenka, Chun-Yun Gao, Anuradha Rampalli,

Progress in Retinal and Eye Research

1997

42

Synthesis of spiro[chroman-2,4′-piperidin]-4-one derivatives as acetyl-CoA carboxylase inhibitors

Pundlik Shinde, Sanjay Srivastava, Rajendra Odedara,

Bioorganic & Medicinal Chemistry Letters

2008

35

The Effect of a Diiodothyronine Mimetic on Insulin Sensitivity in Male Cardiometabolic Patients: A Double-Blind Randomized Controlled Trial

Fleur van der Valk, Carlijne Hassing, Maartje E. Visser,

PLoS ONE

2014

33

Phase I Clinical Studies of the Advanced Glycation End-product (AGE)-Breaker TRC4186

Kumar Prafull Chandra, Ajay Shiwalkar, Jignesh Kotecha,

Clinical Drug Investigation

2009

32

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

Shitalkumar Zambad, Davinder Tuli, A Matur,

Diabetes Metabolic Syndrome and Obesity

2013

31

Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis

Ram P. Gupta, Avinash Jadhav, Shitalkumar Zambad,

Clinical and Experimental Gastroenterology

2014

28

Bacteriophage lambda as a cloning vector.

Vijay Chauthaiwale, A Therwath, Vasanti V. Deshpande

Microbiological Reviews

1992

25

Page 1